Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO > PEER COMPARISON
Peer Comparison      
Sun Pharmaceutical Industries Ltd.
Peer CompaniesPrice(Rs)Chg(Rs) Chg(%)EPS(Rs.)TTM P/EVolume(000's)1Year Return(%)Divinded YieldBook Value
Bharat Parenterals 1089.1 51.85 5 39.52 27.56 787-31.93 0.09 367.05
Mercury Laboratories 877 41.95 5.02 32.88 26.68 1243.09 0.4 423.65
Divi's Lab 6155.9 23 0.38 78.09 78.83 1000255.45 0.49 508.83
Everest Organics 449.95 21.4 4.99 -4.27 0 11530243.34 0 57.3
Alivus Life Sciences 1107.25 20.25 1.86 36.02 30.74 483833.52 2.03 189.45
Procter&Gamble Healt 5038.45 15.45 0.31 142.52 35.35 4757.3 5.16 319.1
NGL Fine-Chem 1120 10 0.9 47.75 23.45 15-52.58 0.16 425.39
Biocon 341.3 5.45 1.62 5.02 68.06 18760413.09 0.15 90.21
Sai Life Sciences 720.8 3.45 0.48 4.57 157.79 12938  0 566.27
Unick Fix-A-Form 62.05 2.95 4.99 4.95 12.53 1682.97 0 56.72
Colinz Laboratories 50.63 2.41 5 1.91 26.52 7339.19 0 35.52
Aayush Wellness 94.09 1.84 1.99 0.5 187.92 215516434.6 0 15.15
Sanofi Cons. Health 4953.4 1.8 0.04 73.08 67.78 482  1.11 118.26
Aarey Drugs & Pharma 53.99 1.29 2.45 2.01 26.84 7561-0.94 0 46.45
Indoco Remedies 238.8 1.2 0.51 5.97 40 4356-28.88 0.63 121.83
Desh Rakshak Aushdh 36.88 0.72 1.99 1.18 31.36 100405.9 0 20.72
Fermenta Biotech 265.4 0.7 0.26 10.55 25.15 602363.22 0.47 104.42
FDC 425.1 0.65 0.15 16.81 25.3 6033-5.31 0 128.81
Ind-Swift Lab. 76.52 0.61 0.8 59.51 1.29 79364-31.77 0 156.08
Venmax Drugs&Pharma 27.81 0.55 2.02 -1.43 0 7673565.31 0 -1.24
Page 1 of 9 Prev || Next
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.